Package 70518-2022-2

Brand: bupropion hydrochloride

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 70518-2022-2
Digits Only 7051820222
Product NDC 70518-2022
Product ID 70518-2022_46001378-4e37-68e7-e063-6394a90a7050
Description

90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-2022-2)

Marketing

Marketing Status
Marketed Since 2025-07-06
Brand bupropion hydrochloride
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Bupropion Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "46001378-4e37-68e7-e063-6394a90a7050", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["740534d3-59b5-4938-8e38-16275a14438c"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-2022-2)", "package_ndc": "70518-2022-2", "marketing_start_date": "20250706"}], "brand_name": "Bupropion Hydrochloride", "product_id": "70518-2022_46001378-4e37-68e7-e063-6394a90a7050", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "70518-2022", "generic_name": "Bupropion Hydrochloride", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA090693", "marketing_category": "ANDA", "marketing_start_date": "20190415", "listing_expiration_date": "20261231"}